|
시장보고서
상품코드
2055296
혈액검사 시장 : 검사 유형별, 기술별, 제품, 용도별, 최종사용자별, 검체 유형별, 지역별Blood Testing Market, By Test Type, By Technology, By Product, By Application, By End User, By Sample Type, By Geography |
||||||
혈액검사 시장은 2026년 1,157억 6,000만 달러로 추정되고, 2033년에 2,129억 7,000만 달러에 이를 것으로 예상되고 있습니다. 또한, 2026-2033년 CAGR 9.1%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 1,157억 6,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 9.10% | 2033년 시장 규모 예측 : | 2,129억 7,000만 달러 |
세계 혈액검사 시장은 의료 진단 산업에서 매우 중요한 분야로, 질병의 발견, 건강 상태 모니터링, 치료 방침 결정 등을 목적으로 혈액 검체를 분석하는 광범위한 임상 검사 및 진단 절차를 포괄하고 있습니다. 혈액검사는 순환기학, 종양학, 감염증, 당뇨병 관리, 정기 건강검진 등 다양한 의료 분야에서 기본적인 진단 도구로 활용되고 있습니다. 이 시장에는 기존의 실험실 기반 검사부터 혁신적인 현장 진단 기기, 분자진단, 자동화된 고성능 시스템에 이르기까지 다양한 검사 기법이 포함되어 있습니다.
당뇨병, 심혈관 질환, 암 등 만성 질환의 유병률이 증가하는 데다 예방 의료와 질환의 조기 발견에 대한 중요성이 부각되면서, 혈액검사 서비스에 대한 수요는 전 세계적으로 계속 확대되고 있습니다. 이 시장은 저침습 검사 절차의 개발, 인공지능(AI) 통합을 통한 정확도 향상, 맞춤형 의료 접근법의 부상 등 급속한 기술적 진보를 특징으로 하고 있습니다. 주요 시장 진출기업으로는 임상 실험실, 병원, 진단센터, 현장 진단(POCT) 장비 제조업체 등이 있으며, 이들 모두 전 세계적인 고령화, 의료 인프라 확충, 의료에 대한 인식 제고에 힘입어 시장이 견조한 성장세를 이어가는 데 기여하고 있습니다.
시장 역학
세계 혈액검사 시장은 지속적인 성장세를 뒷받침하는 몇 가지 강력한 촉진요인에 힘입어 성장하고 있습니다. 주요 촉진요인은 당뇨병, 심혈관 질환, 암, 감염증 등 전 세계적으로 증가하고 있는 만성 질환의 유병률에 있습니다. 이러한 질환들은 효과적인 질환 관리와 치료의 최적화를 위해 정기적인 혈액 모니터링과 진단 검사가 필요합니다. 또한, 고령자들이 빈번한 건강검진과 모니터링을 필요로 하기 때문에 종합적인 혈액검사 서비스에 대한 수요가 증가하고 있으며, 전 세계 인구의 고령화 또한 시장 확대에 크게 기여하고 있습니다. 기술의 발전 또한 중요한 촉진요인 중 하나이며, 현장 검사 장비, 자동화 검사 시스템, 분자진단, AI를 활용한 진단 도구의 혁신을 통해 검사 정확도 향상, 결과 보고까지의 시간 단축, 환자 예후 개선이 이루어지고 있습니다.
예방 의료와 질병 조기 발견에 대한 관심이 높아지면서 시장 성장이 더욱 가속화되고 있습니다. 전 세계의 의료 시스템이 예방적 건강 관리 전략을 우선시하고 있기 때문입니다. 그러나 시장에는 뚜렷한 제약도 존재합니다. 정밀 진단 장비나 검사 절차에 따른 높은 비용이, 특히 의료 예산이 제한적인 개발도상국 지역에서 의료 서비스 이용의 장벽이 될 수 있습니다. 새로운 진단 검사나 기기에 대한 엄격한 규제 요건과 장기화되는 승인 절차는 추가적인 과제가 되어, 시장 진입 지연이나 개발 비용 증가를 초래할 수 있습니다. 또한, 특정 지역의 숙련된 검사 기술자나 기술자 부족은 의료시설 운영에 제약을 주고 있습니다.
그럼에도 불구하고, 맞춤형 의료, 약물유전체학, 동반진단 분야에서 혈액검사의 활용이 확대됨에 따라 환자에게 맞춘 치료 접근이 가능해지면서 큰 기회가 생겨나고 있습니다. 가정용 검사 및 자가 검사 솔루션의 도입 확대는 특히 코로나19 팬데믹이 의료 제공 모델에 미친 영향으로 인해 가속화되어 수익성 높은 기회를 창출하고 있습니다. 아시아·태평양, 라틴아메리카, 아프리카의 신흥 시장에서는 의료 인프라 개선, 의료비 증가, 정기 건강검진 및 진단 검사의 중요성에 대한 인식 제고를 배경으로 큰 성장 가능성이 기대되고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)을 바탕으로 전 세계 혈액검사 시장의 주요 기업 프로파일을 발표하고 있습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 전 세계 혈액검사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 혈액검사 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 혈액검사 시장 : 검사 유형별, 2021-2033년
제5장 세계의 혈액검사 시장 : 기술별, 2021-2033년
제6장 세계의 혈액검사 시장 : 제품별, 2021-2033년
제7장 세계의 혈액검사 시장 : 용도별, 2021-2033년
제8장 세계의 혈액검사 시장 : 최종사용자별, 2021-2033년
제9장 세계의 혈액검사 시장 : 검체 유형별, 2021-2033년
제10장 세계의 혈액검사 시장 : 지역별, 2021-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌과 조사 방법
LSH 26.06.23Blood Testing Market is estimated to be valued at USD 115.76 Bn in 2026 and is expected to reach USD 212.97 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 115.76 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.10% | 2033 Value Projection: | USD 212.97 Bn |
The global blood testing market represents a critical segment of the healthcare diagnostics industry, encompassing a comprehensive range of laboratory tests and diagnostic procedures that analyze blood samples to detect diseases, monitor health conditions, and guide treatment decisions. Blood testing serves as a fundamental diagnostic tool across various medical specialties, including cardiology, oncology, infectious diseases, diabetes management, and routine health screenings. The market encompasses diverse testing methodologies ranging from traditional laboratory-based assays to innovative point-of-care testing devices, molecular diagnostics, and automated high-throughput systems.
With the increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer, coupled with the growing emphasis on preventive healthcare and early disease detection, the demand for blood testing services continues to expand globally. The market is characterized by rapid technological advancements, including the development of minimally invasive testing procedures, enhanced accuracy through artificial intelligence integration, and the emergence of personalized medicine approaches. Key market participants include clinical laboratories, hospitals, diagnostic centers, and point-of-care testing device manufacturers, all contributing to the market's robust growth trajectory driven by aging populations, healthcare infrastructure development, and increased healthcare awareness worldwide.
Market Dynamics
The global blood testing market is propelled by several compelling drivers that fuel its sustained growth trajectory. The primary driver stems from the escalating prevalence of chronic diseases worldwide, including diabetes, cardiovascular disorders, cancer, and infectious diseases, necessitating regular blood monitoring and diagnostic testing for effective disease management and treatment optimization. The aging global population significantly contributes to market expansion as elderly individuals require frequent health screenings and monitoring, driving demand for comprehensive blood testing services. Technological advancements represent another crucial driver, with innovations in point-of-care testing devices, automated laboratory systems, molecular diagnostics, and AI-powered diagnostic tools enhancing testing accuracy, reducing turnaround times, and improving patient outcomes.
The growing emphasis on preventive healthcare and early disease detection further accelerates market growth, as healthcare systems worldwide prioritize proactive health management strategies. However, the market faces notable restraints including high costs associated with advanced diagnostic equipment and testing procedures, which can limit accessibility, particularly in developing regions with constrained healthcare budgets. Stringent regulatory requirements and lengthy approval processes for new diagnostic tests and devices pose additional challenges, potentially delaying market entry and increasing development costs. The shortage of skilled laboratory professionals and technicians in certain regions creates operational constraints for healthcare facilities.
Nevertheless, significant opportunities emerge from the expanding applications of blood testing in personalized medicine, pharmacogenomics, and companion diagnostics, enabling tailored treatment approaches. The growing adoption of home-based and self-testing solutions presents lucrative opportunities, particularly accelerated by the COVID-19 pandemic's impact on healthcare delivery models. Emerging markets in Asia Pacific, Latin America, and Africa offer substantial growth potential driven by improving healthcare infrastructure, increasing healthcare expenditure, and rising awareness about the importance of regular health screenings and diagnostic testing.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global blood testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Thermo Fisher Scientific Inc., Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Becton Dickinson and Company (BD), Ortho Clinical Diagnostics, Quest Diagnostics Incorporated, PerkinElmer Inc., Grifols S.A., bioMerieux SA, Cepheid (Danaher Corporation), DiaSorin S.p.A., and Nova Biomedical
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global blood testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood testing market
Market Segmentation
- Test Type Insights (Revenue, USD Bn, 2021 - 2033)
- Clinical Chemistry
- Basic/Lipid Metabolic Panels
- Electrolyte Panel
- Liver Function Tests
- Renal Function Tests
- Thyroid Function Tests
- Blood Glucose Tests
- Hematology and Coagulation
- Complete Blood Count (CBC)
- Platelet Count and Function Tests
- Prothrombin Time/International Normalized Ratio
- Activated Partial Thromboplastin Time (aPTT)
- Immunoassay and Serology
- Autoimmune Disease Testing
- Allergy Testing
- Cancer Biomarker Tests
- Hormone Level Testing
- Molecular Blood Tests
- Nucleic Acid Testing (NAT) for Infectious Diseases
- Pharmacogenomics
- Oncology (Liquid Biopsy)
- Microbiology
- Blood Culture Tests
- Gram Stains
- Others
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Immunoassay
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing (NGS)
- Microarray
- Clinical Chemistry Analysis
- Hematology Analyzers
- Mass Spectrometry
- Flow Cytometry
- Product Insights (Revenue, USD Bn, 2021 - 2033)
- Reagents and Kits
- Instruments and Analyzers
- Consumables (tubes, slides, etc.)
- Software and Services
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Disease Diagnosis
- Wellness and Health Monitoring
- Therapeutic Drug Monitoring
- Pre-Natal Screening
- Pre-Operative Testing
- Drug of Abuse Testing
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Diagnostic Laboratories
- Blood Banks
- Research Institutes and Academia
- Home Care and Self-Testing Users
- Sample Type Insights (Revenue, USD Bn, 2021 - 2033)
- Whole Blood
- Serum
- Plasma
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott Laboratories
- Hoffmann-La Roche Ltd
- Siemens Healthineers
- Thermo Fisher Scientific Inc.
- Beckman Coulter Inc. (Danaher Corporation)
- Bio-Rad Laboratories Inc.
- Becton Dickinson and Company (BD)
- Ortho Clinical Diagnostics
- Quest Diagnostics Incorporated
- PerkinElmer Inc.
- Grifols S.A.
- bioMerieux SA
- Cepheid (Danaher Corporation)
- DiaSorin S.p.A.
- Nova Biomedical
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Blood Testing Market, By Test Type
- Global Blood Testing Market, By Technology
- Global Blood Testing Market, By Product
- Global Blood Testing Market, By Application
- Global Blood Testing Market, By End User
- Global Blood Testing Market, By Sample Type
- Global Blood Testing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Blood Testing Market, By Test Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Clinical Chemistry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Basic/Lipid Metabolic Panels
- Electrolyte Panel
- Liver Function Tests
- Renal Function Tests
- Thyroid Function Tests
- Blood Glucose Tests
- Hematology and Coagulation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Complete Blood Count (CBC)
- Platelet Count and Function Tests
- Prothrombin Time/International Normalized Ratio
- Activated Partial Thromboplastin Time (aPTT)
- Immunoassay and Serology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Autoimmune Disease Testing
- Allergy Testing
- Cancer Biomarker Tests
- Hormone Level Testing
- Molecular Blood Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Nucleic Acid Testing (NAT) for Infectious Diseases
- Pharmacogenomics
- Oncology (Liquid Biopsy)
- Microbiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Blood Culture Tests
- Gram Stains
- Others
5. Global Blood Testing Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Immunoassay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Microarray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Clinical Chemistry Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hematology Analyzers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Mass Spectrometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Flow Cytometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Blood Testing Market, By Product, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Reagents and Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Instruments and Analyzers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Consumables (tubes, slides, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Blood Testing Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Disease Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Wellness and Health Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Therapeutic Drug Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pre-Natal Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pre-Operative Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Drug of Abuse Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Blood Testing Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Blood Banks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research Institutes and Academia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Care and Self-Testing Users
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Blood Testing Market, By Sample Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Whole Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Serum
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Plasma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Blood Testing Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Beckman Coulter Inc. (Danaher Corporation)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton Dickinson and Company (BD)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ortho Clinical Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quest Diagnostics Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Grifols S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- bioMerieux SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cepheid (Danaher Corporation)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- DiaSorin S.p.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nova Biomedical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About Us
